GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...
GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...
A new global survey shows that 56.6% of Indian participants aged 50 and above know little to nothing about shingles, although ...
Advt Dr. Shalini Menon, Medical Director at GSK India, noted, “As we age, our natural ability to fight disease diminishes, making us more susceptible to various illnesses like shingles.
India Today on MSN11d
Many Indians over 50 unaware of shingles disease, despite being at high riskA majority of Indians who have the virus causing shingles, a painful age-related disease, are unaware of it. As per the ...
The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...
Previously, he was senior director of public affairs, communications, and sustainability for India and Southwest Asia at The ...
Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, ...
adjuvanted), as the company spearheads the expansion of adult immunization in India. Commenting on the results, Bhushan Akshikar, Managing Director of GlaxoSmithKline Pharmaceuticals Limited ...
Dilruba, starring Kiran Abbavaram, Rukshar Dhillon, and Kathy Davison, hit theaters on March 14, 2025. Directed by Viswa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback